{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:41:43Z","timestamp":1792680103627,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.spen.2024.101171","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T18:38:17Z","timestamp":1731177497000},"page":"101171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neurofibromatosis type 2-related schwannomatosis - An update"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-0371","authenticated-orcid":false,"given":"Manikum","family":"Moodley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsey","family":"Ortman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2024.101171_bib0001","series-title":"Ocular Manifestations of Neuro-Oculo-Cutaneous Syndromes","author":"Moodley","year":"2024"},{"issue":"2","key":"10.1016\/j.spen.2024.101171_bib0002","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.spen.2024.101171_bib0003","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis","volume":"18","author":"Lee","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2024.101171_bib0004","unstructured":"Lu-Emerson C.;. Plotkin S.R. The neurofibromatoses. Part 2: NF2 and schwannomatosis. Rev Neurol Dis 2009 6:3: E81-E86."},{"issue":"4","key":"10.1016\/j.spen.2024.101171_bib0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-019-02029-5","article-title":"An update on the CNS manifestations of neurofibromatosis type 2","volume":"139","author":"Coy","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.spen.2024.101171_bib0006","first-page":"9","article-title":"Erratum in: Acta Neuropathol. 2020 Apr;139(4):667. Ardern-Holmes S, Fisher G, North K. Neurofibromatosis type 2: presentation, major complications, and management, with a focus on the pediatric age group","volume":"32","year":"2019","journal-title":"J Child Neurol"},{"issue":"9","key":"10.1016\/j.spen.2024.101171_bib0007","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","article-title":"International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Wolkenstein P, Evans DG. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation","volume":"24","author":"Plotkin","year":"2022","journal-title":"Genet Med."},{"issue":"10","key":"10.1016\/j.spen.2024.101171_bib0008","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1212\/WNL.0000000000008065","article-title":"Neurofibromatosis 2 in children presenting during the first decade of life","volume":"93","author":"Gaudioso","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.spen.2024.101171_bib0009","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1227\/neu.0000000000002436","article-title":"Stereotactic radiosurgery for vestibular Schwannoma in neurofibromatosis type 2: an international multicenter case series of response and malignant transformation risk","volume":"92","author":"Bin-Alamer","year":"2023","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.spen.2024.101171_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11060-023-04530-0","article-title":"Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective","volume":"166","author":"Shinya","year":"2024","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.spen.2024.101171_bib0011","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1017\/S0022215100134292","article-title":"Cochlear implantation in an intralabyrinthine acoustic neuroma patient after resection of an intracanalicular tumour","volume":"110","author":"Tono","year":"1996","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.spen.2024.101171_bib0012","first-page":"47","volume":"109","author":"Chung","year":"2018"},{"issue":"3","key":"10.1016\/j.spen.2024.101171_bib0013","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/00034894221091010","article-title":"Efficacy of cochlear implantation in neurofibromatosis type 2 related hearing loss","volume":"132","author":"Sobczak","year":"2023","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"12","key":"10.1016\/j.spen.2024.101171_bib0014","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/0003489420935482","article-title":"Ipsilateral cochlear implantation in the presence of observed and irradiated vestibular schwannomas","volume":"129","author":"Urban","year":"2020","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"8","key":"10.1016\/j.spen.2024.101171_bib0015","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/cancers16081479","article-title":"Bevacizumab treatment for patients with NF2-related schwannomatosis: a single center experience","volume":"16","author":"Douwes","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.spen.2024.101171_bib0016","article-title":"A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosis","volume":"5","author":"Chiranth","year":"2023","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.spen.2024.101171_bib0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jocn.2021.01.010","article-title":"Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: systematic review and case","volume":"86","author":"Snyder","year":"2021","journal-title":"J Clin Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.spen.2024.101171_bib0018","article-title":"The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis","volume":"5","author":"Gregory","year":"2023","journal-title":"Neurooncol Adv"},{"issue":"2","key":"10.1016\/j.spen.2024.101171_bib0019","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40487-024-00279-2","article-title":"Gene therapy for neurofibromatosis type 2-related schwannomatosis: recent progress, challenges, and future directions","volume":"12","author":"Yuan","year":"2024","journal-title":"Oncol Ther"},{"issue":"1","key":"10.1016\/j.spen.2024.101171_bib0020","first-page":"vdaa153","article-title":"New developments in neurofibromatosis type 2 and vestibular schwannoma","volume":"3","author":"Ren","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"3","key":"10.1016\/j.spen.2024.101171_bib0021","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11060-017-2690-7","article-title":"Spinal ependymomas in NF2: a surgical disease?","volume":"136","author":"Kalamarides","year":"2018","journal-title":"J Neurooncol"},{"issue":"12","key":"10.1016\/j.spen.2024.101171_bib0022","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1007\/s10072-021-05193-3","article-title":"Omar AT 2nd. Efficacy of aspirin for sporadic vestibular schwannoma: a meta-analysis","volume":"42","author":"Ignacio","year":"2021","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.spen.2024.101171_bib0023","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00006123-199605000-00004","article-title":"The neuroimaging and clinical spectrum of neurofibromatosis 2","volume":"38","author":"Mautner","year":"1996","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.spen.2024.101171_bib0024","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3171\/2020.3.JNS192382","article-title":"Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients","volume":"134","author":"Abi Jaoude","year":"2020","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.spen.2024.101171_bib0025","first-page":"213","article-title":"Auditory brainstem implants for hearing rehabilitation in NF2-schwannomatosis: a systematic review and single-arm meta-analysis","volume":"54","author":"Wang","year":"2024","journal-title":"NeuroRehabilitation"},{"issue":"10","key":"10.1016\/j.spen.2024.101171_bib0026","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","article-title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.spen.2024.101171_bib0027","article-title":"Prospective phase II trial of the dual mTORC1\/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2","volume":"5","author":"Jordan","year":"2023","journal-title":"Neurooncol Adv"},{"issue":"3","key":"10.1016\/j.spen.2024.101171_bib0028","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1200\/JCO.21.02371","article-title":"Alliance A071401: phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations","volume":"41","author":"Brastianos","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.spen.2024.101171_bib0029","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11060-018-2922-5","article-title":"Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2","volume":"139","author":"Osorio","year":"2018","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.spen.2024.101171_bib0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00401-021-02304-4","article-title":"Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype","volume":"141","author":"Kresbach","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1016\/j.spen.2024.101171_bib0031","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jmedgenet-2015-103290","article-title":"English specialist NF2 Research Group; Friedman JM, Evans DG. Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients","volume":"52","author":"Hexter","year":"2015","journal-title":"J Med Genet"},{"issue":"8","key":"10.1016\/j.spen.2024.101171_bib0032","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1007\/s00405-024-08601-4","article-title":"Natural history of hearing and tumor growth in vestibular schwannoma in neurofibromatosis type 2-related schwannomatosis","volume":"281","author":"Wakabayashi","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.spen.2024.101171_bib0033","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/neuonc\/noaa284","article-title":"Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution","volume":"23","author":"Forde","year":"2021","journal-title":"Neuro Oncol"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909124000573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909124000573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T15:19:20Z","timestamp":1732979960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909124000573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":33,"alternative-id":["S1071909124000573"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2024.101171","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis type 2-related schwannomatosis - An update","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2024.101171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101171"}}